About StaphOff Biotech

About company

StaphOff Biotech, Inc., a pharmaceutical company, develops medical products that prevent or stop resistant staphylococcal infections. The company is involved in developing CEN-101, a molecule that could be used as a topical drug, as a locally injectable drug, and as an intravenously administered drug, as well as in a device coating solution and in a sterile-lock to prevent or treat staphylococcal infections. The company was incorporated in 2011 and is based in Hopkinton, Massachusetts.